Guidelines

Immune dysregulation in MDS and MPN: An immunological mess – Part 1

May 2023
BHS guidelines on the management of relapsed and refractory diffuse large B-cell lymphoma: Part 1

May 2023
Diagnosis and treatment of Waldenström Macroglobulinaemia

May 2023
Systemic bevacizumab to treat refractory bleeding in hereditary haemorrhagic telangiectasia: A single centre case series

May 2023
Outpatient management of patients with acute myeloid leukaemia during intensive consolidation chemotherapy: A feasibility study

May 2023
Journal Scan

May 2023
New haematology reimbursements in Belgium

May 2023
Sickle cell disease: A neglected haemoglobinopathy disorder with a huge global burden

March 2023
Venetoclax-Azacitidine, the new standard of care for AML patients unfit for intensive treatment: A guide for clinical practice

March 2023
Bispecific antibodies for the treatment of lymphomas

March 2023

Top